Serpin mutagenesis

被引:4
作者
Antalis, TM [1 ]
Lawrence, DA [1 ]
机构
[1] Amer Red Cross, Jerome H Holland Lab Biomed Sci, Dept Vasc Biol, Rockville, MD 20855 USA
关键词
mutagenesis; serpin; site-directed; random; plasminogen activator inhibitor; PAI-1; PAI-2;
D O I
10.1016/S1046-2023(03)00204-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Mutagenesis represents a powerful methodology for the analysis of protein structural and functional relationships and dissection of complex protein-protein interactions. The suicide substrate-like inhibitory mechanism of the proteins of the serpin superfamily offers unique challenges for the design of mutagenesis studies. All serpins share a well-characterized core structure and most adopt a metastable conformation that is required for inhibitory activity. Mutagenesis studies focused on the reactive center loop, the hinge region, protease-binding exo-sites, conformational stability, and accessory ligand binding domains have led to a well-established serpin inhibitory mechanism and have defined specific biological interactions and functions for a number of serpins in development, homeostasis, and host defense. Nonetheless, great care must be taken in the design and interpretation of serpin mutagenesis studies, since the rapid conformational changes that occur during serpin inhibition can be affected at many levels. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:130 / 140
页数:11
相关论文
共 67 条
[1]   CRYSTALLIZATION AND X-RAY-DIFFRACTION DATA OF THE CLEAVED FORM OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
AERTGEERTS, K ;
DEBONDT, HL ;
DERANTER, C ;
DECLERCK, PJ .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1995, 23 (01) :118-121
[2]   CLONING AND EXPRESSION OF A CDNA CODING FOR A HUMAN MONOCYTE-DERIVED PLASMINOGEN-ACTIVATOR INHIBITOR [J].
ANTALIS, TM ;
CLARK, MA ;
BARNES, T ;
LEHRBACH, PR ;
DEVINE, PL ;
SCHEVZOV, G ;
GOSS, NH ;
STEPHENS, RW ;
TOLSTOSHEV, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (04) :985-989
[3]   MOLECULAR EVOLUTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 FUNCTIONAL STABILITY [J].
BERKENPAS, MB ;
LAWRENCE, DA ;
GINSBURG, D .
EMBO JOURNAL, 1995, 14 (13) :2969-2977
[4]   Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis [J].
Björquist, P ;
Ehnebom, J ;
Inghardt, T ;
Hansson, L ;
Lindberg, M ;
Linschoten, M ;
Strömqvist, M ;
Deinum, J .
BIOCHEMISTRY, 1998, 37 (05) :1227-1234
[5]   The role of strand 1 of the C β-sheet in the structure and function of α1-antitrypsin [J].
Bottomley, SP ;
Lawrenson, ID ;
Tew, D ;
Dai, WW ;
Whisstock, JC ;
Pike, RN .
PROTEIN SCIENCE, 2001, 10 (12) :2518-2524
[6]  
Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28
[7]   The P-6-P-2 region of serpins is critical for proteinase inhibition and complex stability [J].
ChaillanHuntington, CE ;
Gettins, PGW ;
Huntington, JA ;
Patston, PA .
BIOCHEMISTRY, 1997, 36 (31) :9562-9570
[8]   Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence - Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin [J].
Chuang, YJ ;
Swanson, R ;
Raja, SM ;
Olson, ST .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :14961-14971
[9]   REACTIVE-SITE MUTANTS OF RECOMBINANT PROTEIN-C INHIBITOR [J].
COOPER, ST ;
CHURCH, FC .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1995, 1246 (01) :29-33
[10]   PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA-INDUCED APOPTOSIS - EVIDENCE FOR AN ALTERNATE BIOLOGICAL FUNCTION [J].
DICKINSON, JL ;
BATES, EJ ;
FERRANTE, A ;
ANTALIS, TM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27894-27904